IL141913A0 - Micronised pharmaceutical compositions - Google Patents

Micronised pharmaceutical compositions

Info

Publication number
IL141913A0
IL141913A0 IL14191399A IL14191399A IL141913A0 IL 141913 A0 IL141913 A0 IL 141913A0 IL 14191399 A IL14191399 A IL 14191399A IL 14191399 A IL14191399 A IL 14191399A IL 141913 A0 IL141913 A0 IL 141913A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
micronised
micronised pharmaceutical
pharmaceutical
lactose
Prior art date
Application number
IL14191399A
Other languages
English (en)
Original Assignee
Pharmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10839350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141913(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmax Ltd filed Critical Pharmax Ltd
Publication of IL141913A0 publication Critical patent/IL141913A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14191399A 1998-09-23 1999-09-22 Micronised pharmaceutical compositions IL141913A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820746.7A GB9820746D0 (en) 1998-09-23 1998-09-23 Micronised pharmaceutical compositions
PCT/GB1999/003172 WO2000016745A2 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL141913A0 true IL141913A0 (en) 2002-03-10

Family

ID=10839350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14191399A IL141913A0 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Country Status (20)

Country Link
EP (1) EP1115380B2 (da)
JP (1) JP5165168B2 (da)
CN (1) CN1148168C (da)
AT (1) ATE267585T1 (da)
AU (1) AU752266B2 (da)
BR (2) BRPI9914031B8 (da)
CA (1) CA2341366C (da)
CZ (1) CZ298603B6 (da)
DE (1) DE69917658T3 (da)
DK (1) DK1115380T4 (da)
EA (1) EA003193B1 (da)
ES (1) ES2222733T5 (da)
GB (1) GB9820746D0 (da)
HU (1) HU228888B1 (da)
IL (1) IL141913A0 (da)
MX (1) MXPA01003103A (da)
NZ (1) NZ509881A (da)
PL (1) PL197871B1 (da)
PT (1) PT1115380E (da)
WO (1) WO2000016745A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
US10441536B2 (en) * 2013-03-13 2019-10-15 Actavis Group Ptc Ehf Micronized colistimethane sodium pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
IT1228459B (it) † 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8911259D0 (en) † 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5916596A (en) † 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5875776A (en) † 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
WO1998020836A2 (en) * 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

Also Published As

Publication number Publication date
HUP0104928A2 (hu) 2002-04-29
DE69917658D1 (de) 2004-07-01
JP2002526435A (ja) 2002-08-20
WO2000016745A2 (en) 2000-03-30
ES2222733T5 (es) 2008-06-16
EP1115380B2 (en) 2008-03-12
PT1115380E (pt) 2004-10-29
CN1148168C (zh) 2004-05-05
CZ298603B6 (cs) 2007-11-21
EA200100253A1 (ru) 2001-08-27
ATE267585T1 (de) 2004-06-15
PL346774A1 (en) 2002-02-25
AU752266B2 (en) 2002-09-12
CZ20011050A3 (cs) 2001-09-12
CN1321082A (zh) 2001-11-07
MXPA01003103A (es) 2005-02-17
AU6212299A (en) 2000-04-10
HU228888B1 (en) 2013-06-28
DE69917658T2 (de) 2005-06-09
ES2222733T3 (es) 2005-02-01
EP1115380A2 (en) 2001-07-18
NZ509881A (en) 2003-01-31
DK1115380T4 (da) 2008-06-16
EP1115380B1 (en) 2004-05-26
DE69917658T3 (de) 2009-04-02
CA2341366A1 (en) 2000-03-30
WO2000016745A3 (en) 2001-05-10
GB9820746D0 (en) 1998-11-18
CA2341366C (en) 2008-11-18
EA003193B1 (ru) 2003-02-27
BR9914031A (pt) 2001-06-19
JP5165168B2 (ja) 2013-03-21
DK1115380T3 (da) 2004-10-04
PL197871B1 (pl) 2008-05-30
BR9914031B1 (pt) 2011-02-08
BRPI9914031B8 (pt) 2019-02-26
HUP0104928A3 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
MY126253A (en) Capsules for inhalation
MY129552A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
NZ336592A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
IL112097A0 (en) Indoline derivatives, their preparation and pharmaceutical compositions containing them
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
IL141913A0 (en) Micronised pharmaceutical compositions
ZA849972B (en) New benzimidazoles,the preparation thereof and pharmaceutical compositions containing these compounds
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
IL70611A (en) Tetrahydrocarbazole derivatives,their preparation and pharmaceutical compositions comprising them
IL112998A0 (en) Taxane derivatives, their preparation and pharmaceutical compositions containing them
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
ZA986730B (en) Streptogramin derivatives their preparation and compositions containing them
AU4535800A (en) Novel 6-phenylpurine 9-beta-d-ribonucleosides with antineoplastic activity, their use for preparing pharmaceutical compositions and pharmaceutical preparations containing such compounds
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
AU8888198A (en) Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same
HRP950267A2 (en) Heterocyclic compounds, pharmaceutical preparations containing them and the preparation thereof
AU5695594A (en) Thio- and oxo-azasteroids, processes for the preparation thereof, use thereof as antiandrogens and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired